s
Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT
27-08-2024, 09:18
BASEL, Switzerland, Aug. 27, 2024 /PRNewswire/ — Vaderis Therapeutics AG (Vaderis), a clinical stage biotechnology company focused on developing treatments for rare diseases associated with vascular malformations, today announces positive results from its randomized, double-blind, dose-finding placebo-controlled Proof-of-Concept (POC) clinical trial in patients suffering from HHT. HHT, an Orphan Disease, is the second […] L'articolo Vaderis Announces Positive Clinical Proof-of-Concept Trial in HHT proviene da La Ragione.
CONTINUA A LEGGERE
9
0
0
Guarda anche
La Ragione
01:43
Tripletta Thuram, Inter batte 3-2 il Torino
La Ragione
Ieri, 21:43
Manovra, Tajani “Extraprofitto incomprensibile, concetto extraterrestre”
La Ragione
Ieri, 19:43
Confesercenti “Tetti agli affitti per le attività di prossimità”
La Ragione
Ieri, 19:43
Scontri a Roma tra i manifestanti pro Palestina e le forze dell’ordine
La Ragione
Ieri, 18:52
Alimentazione, esperti: “Con esercizio fisico pilastri longevità sana”
La Ragione
Ieri, 18:12